Exosome treatment to prevent leakage after rectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This study tests whether giving exosomes (tiny particles that help cells talk to each other) during surgery can reduce the risk of leaks where the intestine is reconnected. It is for people with stage II or III rectal cancer who have had chemo and radiation and are about to have surgery to remove the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage II or III rectal cancer.
- You have already had chemotherapy and radiation before surgery.
- You are scheduled for a surgery called low anterior resection.
- You do not have severe malnutrition (check with your doctor).
- You do not have ongoing chronic lung disease.
- You are not taking high doses of steroids (more than 5 mg of prednisolone per day).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies “exosomes” (tiny cell signals being researched as a possible way to affect cancer treatment) in people with rectal cancer. You would receive standard chemotherapy plus radiation before planned surgery, and the trial looks at outcomes related to that treatment.
This trial tests a surgical technique that recycles intestinal fluids during rectal cancer surgery to help prevent bowel dysfunction and frequent bowel movements after surgery. If you've had mid-to-low rectal cancer removed and created a temporary opening (stoma), this study may help improve your quality of life.
This trial tests whether a short course of radiation before surgery, combined with the immunotherapy drug envafolimab and the chemo regimen CAPEOX, works better for shrinking locally advanced rectal cancer. It is aimed at people whose tumor is not “MMR-deficient” (it is pMMR/MSS), and it asks participants to be able to return for repeated checkups and treatments.
This trial compares two approaches for low-risk locally advanced rectal cancer: going straight to surgery (TME) versus receiving chemotherapy before surgery. The goal is to see if upfront surgery works just as well, sparing patients from chemotherapy side effects.
This study looks at special tiny cell-signal particles (called exosomes) and related pathways to understand colorectal cancer. Your results from samples may help researchers learn how these signals relate to the disease after surgery.
This trial tests whether exosomes (tiny particles) from human umbilical cord stem cells can help treat active ulcerative colitis. It is for people who have not responded well to standard treatments or cannot tolerate them.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.